News | Cardiac Diagnostics | February 20, 2019

PTSD Alone Does Not Increase Heart Disease Risk in Veterans

Coexisting medical conditions, psychiatric disorders, heavy smoking and illicit drug use may explain the increased risk for heart disease among veterans with PTSD

PTSD Alone Does Not Increase Heart Disease Risk in Veterans

February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the increased risk of cardiovascular disease in veterans with this condition. A combination of physical disorders, psychiatric disorders and smoking, that are more common in patients with PTSD, may explain the association, according to new research in Journal of the American Heart Association.

Researchers examined whether one or a combination of heart disease risk factors common in those with PTSD can explain the association between PTSD and cardiovascular disease. They reviewed electronic health records of 2,519 Veterans Affairs (VA) patients diagnosed with PTSD and 1,659 without PTSD. Participants were aged 30-70 (87 percent male; 60 percent white), had no cardiovascular disease diagnoses for 12 months prior and were followed for at least three years.

Researchers found:

  • Among VA patients, those diagnosed with PTSD were 41 percent more likely to develop circulatory and heart disease than those without PTSD;

  • Smoking, depression, other anxiety disorders, sleep disorders, Type 2 diabetes, obesity, high blood pressure and cholesterol were significantly more prevalent among patients with PTSD than those without; and

  • No single comorbid condition explained the association between PTSD and incident cardiovascular disease, after adjusting for a combination of physical and psychiatric disorders, smoking, sleep disorder and substance use disorders, PTSD was not associated with new cases of cardiovascular disease.

“This suggests there is no single comorbidity or behavior that explains the link between PTSD and cardiovascular disease,” said study lead author Jeffrey Scherrer, Ph.D., professor and director, Division of Research in the Department of Family and Community Medicine at the Saint Louis University School of Medicine in Missouri. “Instead, a combination of physical disorders, psychiatric disorders and smoking — that are more common in patients with PTSD versus without PTSD — appear to explain the association between PTSD and developing cardiovascular disease."

Researchers cautioned that the results may not be generalized to patients older than 70 or to non-veteran populations. In addition, the study did not measure lifetime cardiovascular disease risk; therefore, the association between PTSD and risk of cardiovascular disease over many decades may differ from the present results.

“For veterans, and likely non-veterans, heart disease prevention efforts should focus on helping patients reduce weight, control high blood pressure, cholesterol, Type 2 diabetes, depression, anxiety disorders, sleep problems, substance abuse and smoking,” Scherrer said. “That is a long list, and for patients with many of these conditions it is challenging yet important to manage all of them.”

“Recognizing that PTSD does not preordain cardiovascular disease may empower patients to seek care to prevent and/or manage CVD risk factors,” Scherrer said.

For more information: www.ahajournals.org/journal/jaha

Reference

1. Scherrer J.F., Salas J., Cohen B.E., et al. Comorbid Conditions Explain the Association Between Posttraumatic Stress Disorder and Incident Cardiovascular Disease. Journal of the American Heart Association, Feb. 13, 2019. https://doi.org/10.1161/JAHA.118.011133

Related Content

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
Subscribe Now